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ABSTRACT 
Objectives: The aim of the study was to evaluate the protective effect of COX inhibitors on lipopolysaccharide induced sickness behaviour or neuro 
inflammation and oxidative stress on male wistar rats.  
Methods: Male albino wistar rats were divided into 8 groups and each group consisting of 6 rats and drug treatment has done for one week. Control 
group was given normal saline daily by i. p route for 7 days. Negative control group receives saline for 6 days followed by LPS on 7th day. All other 
group receives Resveratrol, Celecoxib, and Aspirin for 7 days and LPS (inducing agent) was given on 7th
Results: The results of this study showed that Celecoxib at 10 and 50 mg/kg p. o. showed no changes in body weight but there is the decrease in the 
temperature, increase in the locomotor activity, increase in the number of line crossing, head dipping/nose poaking, decrease in the floating time 
when compared to the negative control group. Resveratrol at 50 and 100 mg/kg p. o. showed a significant increase in the Superoxide Dismutase, 
Catalase, Glutathione Reductase, and showed significant decrease in the Lipid Peroxide and Nitric Oxide level when compared to the negative 
control group.  
 day just before half an hour of drug 
treatment. After 2 hours of drug administration, the animals were subjected to behavioural testing and after analyzing behavioural parameters, the 
animals were sacrificed by cervical dislocation in order to perform in vitro studies.  
Conclusion: It was finally concluded that Celecoxib showed neuro protective activity and Resveratrol showed anti-oxidant property. 
Keywords: Lipopolysaccharide, Sickness behaviour, COX inhibitors, Oxidative Stress. 
 
INTRODUCTION 
Lipopolysaccharide is as an endotoxin that elicits strong immune 
response in animals and it acts as prototypical endotoxin because it 
binds to CD14/TLR4/MD2 receptor complex that promotes the 
secretion of pro inflammatory cytokines IL-1β, IL-6, TNF-α 
especially in macrophages and β cells [1]. The circulating cytokines 
or other inflammatory mediators that are produced by bacterial 
endotoxin develops sickness behaviour syndrome as well as 
neuroinflammation. Sickness behaviour have been characterized by 
non specific symptoms such as lethargy, depression, anxiety, loss of 
appetite, sleepiness, hyperalgesia, reduction in grooming and failure 
to concentrate [2-7]. In the late phase of an inflammatory response 
in sickness behaviour (also seen during gram negative bacterial 
infections) [8], LPS creates an abundance of reactive oxygen species 
(ROS) primarily from macrophages and infiltrating neutrophils. ROS 
serve as an intracellular messenger to induce signal transduction 
and activate transcription factors such as nuclear factor kappa B 
(NFkB); therefore, production of ROS is an important one for host 
defense and may influence sickness behaviour via NFkB-dependent 
cytokine production [9]. Sickness behaviour or Neuroinflammation 
can be treated with Steroids like glucocorticoid, dexamethasone, 
Non steroidal anti-inflammatory drugs (NSAIDs) like selective COX 1 
inhibitor (Resveratrol), selective COX 2 inhibitor (Celecoxib, 
Rofecoxib & Etoricoxib) & Non selective COX inhibitors (Aspirin, 
Ibuprofen) and a number of proteins produced by rDNA technology. 
Based on this, the present study was focused to analyse the 
protective effect and antioxidant studies of COX inhibitors. 
MATERIALS AND METHODS 
Animals 
Wistar albino animals (200-250 gms) bred in central animal house 
of C. L. Baid Metha College of pharmacy was used. The animals were 
housed under standard conditions of light and dark cycle with free 
access to food and water. The experimental protocols were 
approved by Institutuional Animal Ethical Committee. (Approval no: 
IAEC/XXXIII/06/CLBMCP/2011 DATED: 27/09/2011) 
Drugs 
Lipopolysaccharide and Resveratrol were dissolved in normal saline 
(0.9% NaCl and DMSO) and given at a dose of 0.5 ml by i. p. injection 
while Celecoxib and Aspirin were prepared in normal saline and 
given at a dose of 0.5 ml by p. o. route. The drug solutions were 
prepared freshly at the beginning of each experiment. 
Experimental protocol 
Male albino wistar rats were divided into 8 groups and each group 
consisting of 6 rats. The drug treatment has done for one week 
according to the plan of study.  
Group I:-Normal control treated with saline (0.5 ml-1 ml i. p)  
Group II:-Negative control; saline for 6 days and LPS on 7th day 
followed by saline administration.  
Group III:-Pre-treatment with Selective COX-1 inhibitor, Resveratrol 
(50 mg/kg p. o) for 6 days and LPS on 7th day followed by 
Resveratrol administration.  
Group IV:-Pre-treatment with Selective COX-1 inhibitor, Resveratrol 
(100 mg/kg p. o) for 6 days and LPS on 7th day followed by 
Resveratrol administration.  
Group V:-Pre-treatment with Selective COX-2 inhibitor, Celecoxib 
(10 mg/kg p. o) for 6 days and LPS on 7th day followed by Celecoxib 
administration.  
Group VI:-Pre-treatment with Selective COX-2 inhibitor, Celecoxib 
(50 mg/kg p. o) for 6 days and LPS on 7th day followed by Celecoxib 
administration.  
Group VII:-Pre-treatment with Non Selective COX inhibitor, Aspirin 
(100 mg/kg p. o) for 6 days and LPS on 7th day followed by Aspirin 
administration.  
Group VIII:-Pre-treatment with Non Selective COX inhibitor, Aspirin 
(200 mg/kg p. o) for 6 days and LPS on 7th day followed by Aspirin 
administration.  
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Before administration of the drug, body temperature [10] and rectal 
temperature[11] were recorded. After 2 hours of drug 
administration, body temperature, rectal temperature and 
behavioural testing were performed. After analyzing behavioural 
parameters, the animals were sacrificed by cervical dislocation in 
order to perform in vitro studies. The animals were sacrificed by 
cervical dislocation in order to perform in vitro studies. Rat brain 
was removed and rinsed with normal saline and the homogenate 
prepared in 10%(w/v) cold phosphate buffered saline (0.1 mol/l, pH 
7.4) with the help of homogenizer were used for the study. 
Assessment of locomotor behaviour [12] 
The locomotor activity can be easily studied with the help of 
actophotometer, for this albino rats were divided into eight groups, 
each group comprising of six animals. The cytophotometer consists 
of a square arena (30 × 30 × 25 cm) with the wire mesh bottom, in 
which the animal moves. Six lights and six photocells were placed in 
the outer periphery of the bottom in such a way that a single rat can 
block only one beam. The movement of the animal interrupts a beam 
of light falling on a photocell, at which a count was recorded and 
displayed digitally. The locomotor activity was measured for a 
period of 10 min. Technically its principle is that, a photocell is 
activated when the rays of light falling on the photocells are cut off 
by animals crossing the beam of light. As the photocell activated, a 
count is recorded.  
Assessment of behavioural parameters 
Hole board test [13] 
Exploratory behaviour was evaluated in an open-field paradigm. The 
open field was made up of plywood and comprises of 40 X 50 X 60 cm 
dimensions. The entire apparatus was painted black and was divided 
into 16 squares with white lines on the floor. Each animal was placed at 
one corner of the apparatus and for the next 5 minutes they were 
observed for their ambulation such as line crossings and head dipping.  
Forced swim test [13] 
Male Albino rats weighing 200-250 g are used. They are brought to the 
laboratory at least one day before the experiment and are housed 
separately in Makrolon cages with free access to food and water. Rats are 
individually forced to swim inside a vertical Plexiglas cylinder (height: 40 
cm; diameter: 18 cm, containing 15 cm of water maintained at 25 °C). 
Rats placed in the cylinders for the first time are initially highly active, 
vigorously swimming in circles, trying to climb the wall or diving to the 
bottom. After 2–3 min activity begins to subside and to be interspersed 
with phases of immobility or floating of increasing length. After 5–6 min 
immobility reaches a plateau where the rats remain immobile for 
approximately 80% of the time. After 15 min in the water, the rats are 
removed and allowed to dry in a heated enclosure (32 °C) before being 
returned to their home cages. They are again placed in the cylinder 24 h 
later and the total duration of immobility is measured during a 5 min 
test. Floating behaviour during this 5 min period has been found to be 
reproducible in different groups of rats. An animal is judged to be 
immobile whenever it remains floating passively in the water in a 
slightly hunched but upright position, its nose just above the surface. 
Each animal was placed water and for the next 5 minutes they were 
observed for floating time.  
Assessment of anti oxidant enzymes 
Estimation of superoxide dismutase (SOD) [14] 
The SOD activity in supernatant was measured by the method of 
Misra and Fridovich. The supernatant (500μl) was added to 0.800 ml 
of carbonate buffer (100 mM, pH 10.2) and 100μl of epinephrine (3 
mM). The change in absorbance of each sample was then recorded at 
480 nm in spectrophotometer for 2 min at an intervals of 15 sec. 
Parallel blank and standard were run for determination SOD activity. 
One unit of SOD is defined as the amount of enzyme required to 
produce 50% inhibition of epinephrine auto oxidation. 
Estimation of catalase (CAT) [15] 
Catalase activity was measured by the method of Aebi. 0.1 ml of 
supernatant was added to cuvette containing 1.9 ml of 50 mM 
phosphate buffer (pH 7.0). Reaction was started by the addition of 
1.0 ml of freshly prepared 30 mM H2O2. The rate of decomposition 
of H2O2 was measured spectrophotometrically from changes in 
absorbance at 240 nm. Activity of catalase was expressed as 
units/mg protein. A unit is defined as the velocity constant per 
second. 
Estimation of lipid peroxidase (LPO) [16]  
The level of Lipid peroxides was estimated by Thiobarbituric acid 
reaction method described by Ohkawa et al.212. To 0.2 ml of test 
sample, 0.2 ml of SDS, 1.5 ml of acetic acid and 1.5 ml of TBA were 
added. The mixture was made up to 4 ml with water and then heated 
in a water bath at 95 °C for 60 minutes. After cooling, 1 ml of water 
and 5 ml of n-butanol/pyridine mixture were added and shaken 
vigorously. After centrifugation at 4000 rpm for 10 minutes, the 
organic layer was taken and its absorbance was read at 532 nm. The 
level of lipid peroxides was expressed as n moles of MDA released/g 
wet tissue. 
Estimation of glutathione reductase (GRD) [17] 
Glutathione reductase was assayed by the method of Stahl et al. The 
reaction mixture containing 1 ml phosphate buffer, 0.5 ml EDTA, 0.5 
ml GSSG and 0.2 ml of NADPH was made up to 3 ml with distilled 
water. After the addition of 0.1 ml of tissue homogenate, the change 
in optical density at 340 nm was monitored for 2 minutes at 30 
seconds interval. One unit of the enzyme activity was expressed as n 
moles of NADPH oxidized/min/mg protein. 
Estimation of reactive nitrite species [18]  
Nitrite/nitrate species concentration was estimated in the brain by 
using Griess reagent. 100μl of sample was mixed with 100μl of 
freshly prepared Griess reagent (mixture of 0.1% N-1-napthyl-
ethylenediamine in water and 1% sulphanilamide in 5% phosphoric 
acid) and absorbance was observed at 540 nm using Biorad ELISA 
reader. The levels were expressed as μg/ml of plasma. 
Statistical analysis  
The statistical analysis was carried by one way ANNOVA followed by 
Dunnet´s ‘t’test. P values p<0.001 was considered statistically 
significant using software Graph Pad Prism 5. 
RESULTS 
Effect of resveratrol, celecoxib and aspirin on body weight 
There was a significant (p<0.001) decrease in body weight produced 
by negative control group animals when compared with control 
groups. Treatment with Celecoxib (50 mg/kg p. o.) and aspirin (200 
mg/kg p. o.) does not show any significant difference between 
before and after treatment. Results are given in table 1  
Effect of resveratrol, celecoxib and aspirin on rectal 
temperature  
Rectal temperature in negative control group animals were 
increased significantly (p<0.001) on comparison with control group 
animals. Treatment with Celecoxib (10 and 50 mg/kg p. o) and 
Aspirin (100 and 200 mg/kg p. o) showed significant (p<0.01) 
decrease in rectal temperature on comparison between before and 
after treatment. Results are given in table 2  
Effect of resveratrol, celecoxib and aspirin on locomotor 
activity 
There was a significant (p<0.001) decrease in the activity scores 
produced by Negative control group animals when compared with 
control group animals. Treatment with Celecoxib (50 mg/kg p. o.) 
and Aspirin (100 and 200 mg/kg p. o.) showed significant (p<0.001, 
p<0.05 and p<0.001) increase in the activity scores on comparison 
with Negative control group animals. Results are given in table 3.  
Effect of resveratrol, celecoxib and aspirin in hole board model 
The negative control group animals exhibited decreased line 
crossings and head dippings on comparison with control group 
animals (p<0.001). Treatment with Celecoxib (10 and 50 mg/kg p. o) 
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and Aspirin (200 mg/kg p. o) showed significant (p<0.05, p<0.01 
and p<0.001) difference, in head dipping behaviour on comparison 
with negative control group animals. There was no significant 
difference in head dipping behaviour between negative group 
animals and Resveratrol (50 and 100 mg/kg p. o.) treated animals. 
Treatment with Resveratrol (100 mg/kg p. o.), Celecoxib (10 and 50 
mg/kg p. o.) and Aspirin (100 and 200 mg/kg p. o.) showed 
significant (p<0.001, p<0.01, p<0.001, p<0.001 and p<0.001) 
increase in line crossing behavior on comparison with negative 
group animals. Results are given in table 4. 
Effect of resveratrol, celecoxib and aspirin in forced swimming test 
There was significant (p<0.001) increase in floating time in negative 
control group animals on comparison with control group animals. 
Treatment with Resveratrol (50 and 100 mg/kg p. o.) and Celecoxib 
(10 mg/kg p. o.) does not show any significant difference in floating 
time when compared with negative group animals. There was 
significant (p<0.001) decrease in floating time with Celecoxib, (50 
mg/kg p. o) and Aspirin (100 and 200 mg/kg p. o) treated animals 
on comparison with negative group animals. Results are given in 
table 5 
Effect of resveratrol, celecoxib and aspirin on superoxide 
dismutase (sod) levels  
The negative control group animals showed significant (p<0.001) 
decrease in SOD level when compared to control group animals. The 
Celecoxib (10 and 50 mg/kg) treated animals did not show any 
significant increase while Resveratrol (50 and 100 mg/kg) showed 
significant (p<0.01 and p<0.001) increase when compared to 
negative group animals. Aspirin (100 and 200 mg/kg) treated 
animals showed significant (p<0.001) increase in brain SOD level. 
Results are given in Table-6 and fig 6. 
Effect of drugs resveratrol, celecoxib and aspirin on catalase  
The negative control group animals showed significant (p<0.001) 
decrease in catalase level when compared to control group animals. 
The Celecoxib (10 mg/kg) treated animals did not show any 
significant increase while Celecoxib (50 mg/kg), Resveratrol (50 and 
100 mg/kg) showed significant (p<0.01, p<0.01 and p<0.001) 
increased brain catalase levels when compared to negative group 
animals. Aspirin (100 and 200 mg/kg) treated animals showed 
significant (p<0.001)increase in brain Catalase level. Results are 
given in table 7  
Effect of drugs resveratrol, celecoxib and aspirin on lipid 
peroxide level  
The negative control group animals showed significant (p<0.001) 
decrease in LPO level when compared to control group animals. The 
Celecoxib (10 mg/kg) treated animals did not show any significant 
increase while Celecoxib (50 mg/kg), Resveratrol (50 and 100 
mg/kg) showed significant (p<0.01, p<0.05 and p<0.001) increased 
brain catalase levels when compared to negative group animals. 
Aspirin (100 and 200 mg/kg) treated animals showed significant 
(p<0.001) increase in brain LPO level. Results are given in table 8  
Effect of drugs resveratrol, celecoxib and aspirin on glutathione 
reductase  
The negative control group animals showed significant (p<0.001) 
decrease in GRD level when compared to control group animals. The 
Celecoxib (10 and 50 mg/kg) and Resveratrol (50 mg/kg) treated 
animals did not show any significant increase while Resveratrol 
(100 mg/kg) showed significant (p<0.01) increased GRD levels 
when compared to negative group animals. Aspirin (100 and 200 
mg/kg) treated animals showed significant (p<0.01 and p<0.001) 
increase in brain GRD level. Results are given in table 9  
Effect of drugs resveratrol, celecoxib and aspirin on nox levels  
The negative control group animals showed significant (p<0.001) 
decrease in NOx level when compared to control group animals. The 
Celecoxib (10 mg/kg) and Resveratrol (50 mg/kg) treated animals 
did not show any significant increase while Celecoxib (50 mg/kg) 
and Resveratrol (100 mg/kg) showed significant (p<0.05 and 
p<0.01) increased NOx levels when compared to negative group 
animals. Aspirin (100 and 200 mg/kg) treated animals showed 
significant (p<0.01 and p<0.001) increase in brain GRD level. Results 
are given in table 10. 
 
Table 1: Effect of drugs (Resveratrol, Celecoxib, and Aspirin) on body weight 
Groups  Treatment groups  Body weight 
Before treatment After treatment 
I  Control  146.66±3.33  148.00±3.88  
II  Negative Control  197.50±6.02  186.66±7.49  
III  Resveratrol (50 mg/kg p. o.)  177.50±5.12  170.83±3.27  
IV  Resveratrol (100 mg/kg p. o.)  172.50±5.73  172.83±5.9  
V  Celecoxib (10 mg/kg p. o.)  220.83±6.37  221.00±6.26  
VI  Celecoxib (50 mg/kg p. o.)  197.50±3.81  197.83±3.37  
VII  Aspirin (100 mg/kg p. o.)  204.16±3.96  206.66±4.94  
VIII  Aspirin (200 mg/kg p. o.)  195.00±4.47  199.16±6.50  
The values were expressed as mean±SEM of 6 animals, Comparison were made between before and after treatment, Statistical significant test for 
comparison was done by Two way Annova 
 
Table 2: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on rectal temperature 
Groups Treatment groups Rectal temperature (oC) 
Before treatment After treatment  
I  Control  36.51±0.16  36.45±0.15  
II Negative Control  36.78±0.10  38.26±0.18  
III Resveratrol (50 mg/kg p. o.)  36.41±0.21  36.66±0.14ns  
Iv  Resveratrol (100 mg/kg p. o.)  36.90±0.14  36.96±0.19ns  
V  Celecoxib (10 mg/kg p. o.)  37.16±0.13  37.13±0.16**  
VI  Celecoxib (50 mg/kg p. o.)  37.05±0.14  36.98±0.17**  
VII  Aspirin (100 mg/kg p. o.)  37.06±0.12  37.07±0.14**  
VIII  Aspirin (200 mg/kg p. o.)  37.33±0.11  37.15±0.08**  
The values were expressed as mean±SEM of 6 animals, Comparison were made between before and after treatment, Statistical significant test for 
comparison was done by One way Annova, followed by Dunnet´s ‘t’test test, *p<0.05, **p<0.01, ***p<0.001. 
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Table 3: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on locomotor activity 
Groups  Treatment groups  Locomotor activity in scores  
I  Control  320.66±13.60  
II  Negative Control  127.00±11.53  
III  Resveratrol (50 mg/kg p. o.)  126.50±9.95  
IV  Resveratrol (100 mg/kg p. o.)  126.16±8.60  
V  Celecoxib (10 mg/kg p. o.)  167.16±15.38  
VI  Celecoxib (50 mg/kg p. o.)  219±18.60***  
VII  Aspirin (100 mg/kg p. o.)  190.00±14.36*  
VIII  Aspirin (200 mg/kg p. o.)  280.33±15.18***  
The values were expressed as mean±SEM of 6 animals, Comparison were made between Group I with Group II and Group II with III, IV,V,VI,VII,VIII, 
Statistical significant test for comparison was done by One way Annova, followed by Dunnet´s ‘t’test, *p<0.05, **p<0.01, ***p<0.001. 
 
Table 4: Effect of drugs (Resveratrol, Celecoxib, and Aspirin) on hole board model 
Groups  Treatment groups  Line crossings  Head dippings  
I  Control  50.83±0.98  6.50±0.67  
II  Negative Control  19.00±2.26***  1.33±0.49  
III  Resveratrol (50 mg/kg p. o.)  23.16±1.49ns  1.33±0.42ns  
IV  Resveratrol (100 mg/kg p. o.)  33.16±2.08***  1.66±0.42ns  
V  Celecoxib (10 mg/kg p. o.)  29.16±1.99**  3.66±0.49*  
VI  Celecoxib (50 mg/kg p. o.)  39.66±2.24***  4.16±0.54**  
VII  Aspirin (100 mg/kg p. o.)  41.16±1.88***  3.16±0.30ns  
VIII  Aspirin (200 mg/kg p. o.)  47.33±2.20***  5.33±0.49***  
The values were expressed as mean±SEM of 6 animals, Comparison were made between Group I with Group II and Group II with III, IV,V,VI,VII,VIII, 
Statistical significant test for comparison was done by One way Annova, followed by Dunnet´s ‘t’test, *p<0.05, **p<0.01, ***p<0.001 
 
Table 5: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on forced swimming 
Groups  Treatment groups  Floating time in secs  
I  Control  22.33±2.15  
II  Negative Control  142.16±4.42  
III  Resveratrol (50 mg/kg p. o.)  139.00±4.35ns  
IV  Resveratrol (100 mg/kg p. o.)  135±3.84ns  
V  Celecoxib (10 mg/kg p. o.)  127.00±4.05ns  
VI  Celecoxib (50 mg/kg p. o.)  101.00±3.59***  
VII  Aspirin (100 mg/kg p. o.)  59.66±9.35***  
VIII  Aspirin (200 mg/kg p. o.)  38.16±4.35***  
The values were expressed as mean±SEM of 6 animals, Comparison were made between Group I with Group II and Group II with III, IV,V,VI,VII,VIII, 
Statistical significant test for comparison was done by One way Annova, followed by Dunnet´s ‘t’test, *p<0.05, **p<0.01, ***p<0.001. 
 
Table 6: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on superoxide dismutase (SOD) levels 
Groups  Treatment groups  SOD (Units/mg protein)  
I  Control  5.99±0.12  
II  Negative Control  3.06±0.05  
III  Resveratrol (50 mg/kg p. o.)  3.77±0.16**  
IV  Resveratrol (100 mg/kg p. o.)  5.42±0.13***  
V  Celecoxib (10 mg/kg p. o.)  2.85±0.03ns  
VI  Celecoxib (50 mg/kg p. o.)  3.29±0.05ns  
VII  Aspirin (100 mg/kg p. o.)  5.54±0.16***  
VIII  Aspirin (200 mg/kg p. o.)  6.36±0.17***  
The values were expressed as mean±SEM of 6 animals, Comparisons were made between: Group II with Group III, IV,V, VI, VII and VIII , Statistical 
significant test for comparison was done by one way ANNOVA, followed by Dunnet´s ‘t’test, ns-non significant, *p<0.05, **p<0.01, ***p<0.001. 
 
Table 7: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on catalase 
Groups  Treatment groups  Catalase (Units/mg protein)  
I  Control  5.43±0.23  
II  Negative Control  2.78±0.02  
III  Resveratrol (50 mg/kg p. o.)  4.33±0.10**  
IV  Resveratrol (100 mg/kg p. o.)  4.73±0.09***  
V  Celecoxib (10 mg/kg p. o.)  3.08±0.02ns  
VI  Celecoxib (50 mg/kg p. o.)  3.46±0.05**  
VII  Aspirin (100 mg/kg p. o.)  4.22±0.04***  
VIII  Aspirin (200 mg/kg p. o.)  5.82±0.04***  
The values were expressed as mean±SEM of 6 animals, Comparisons were made between: Group II with Group III, IV,V, VI, VII and VIII, Statistical 
significant test for comparison was done by one way ANNOVA, followed by Dunnet´s ‘t’test, ns-non significant, *p<0.05, **p<0.01, ***p<0.001. 
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Table 8: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on lipid peroxides 
Groups  Treatment groups  LPO(units/mg tissue)  
I  Control  137.45±3.07  
II  Negative Control  89.78±1.08  
III  Resveratrol (50 mg/kg p. o.)  98.29±0.56*  
IV  Resveratrol (100 mg/kg p. o.)  105.72±1.45***  
V  Celecoxib (10 mg/kg p. o.)  95.42±1.30ns  
VI  Celecoxib (50 mg/kg p. o.)  100.82±2.40**  
VII  Aspirin (100 mg/kg p. o.)  106.73±3.42***  
VIII  Aspirin (200 mg/kg p. o.)  132.70±1.98***  
The values were expressed as mean±SEM of 6 animals, Comparisons were made between: Group II with Group III, IV,V, VI, VII and VIII, Statistical 
significant test for comparison was done by one way ANNOVA, followed by, Dunnet´s ‘t’test, ns-non significant, *p<0.05, **p<0.01, ***p<0.001. 
 
Table 9: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on glutathione reductase 
Groups  Treatment groups  GRD(units/mg tissue)  
I  Control  2.70±0.66  
II  Negative Control  1.22±0.03  
III  Resveratrol (50 mg/kg p. o.)  1.32±0.025ns  
VI  Resveratrol (100 mg/kg p. o.)  1.75±0.05**  
V  Celecoxib (10 mg/kg p. o.)  1.17±0.04ns  
VI  Celecoxib (50 mg/kg p. o.)  1.33±0.04ns  
VII  Aspirin (100 mg/kg p. o.)  2.26±0.10**  
VIII  Aspirin (200 mg/kg p. o.)  2.56±0.10***  
The values were expressed as mean±SEM of 6 animals, Comparisons were made between: Group II with Group III, IV,V, VI, VII and VIII, Statistical 
significant test for comparison was done by one way ANNOVA, followed by Dunnet´s ‘t’test, ns-non significant, *p<0.05, **p<0.01, ***p<0.001. 
 
Table 10: Effect of drugs (Resveratrol, Celecoxib and Aspirin) on NOx 
Groups  Treatment groups  NOx (units/mg tissue)  
I  Control  0.61±0.1  
II  Negative Control  1.82±0.01  
III  Resveratrol (50 mg/kg p. o.)  1.71±0.02*  
IV  Resveratrol (100 mg/kg p. o.)  1.69±0.03**  
V  Celecoxib (10 mg/kg p. o.)  1.76±0.01ns  
VI  Celecoxib (50 mg/kg p. o.)  1.71±0.03*  
VII  Aspirin (100 mg/kg p. o.)  0.75±0.01**  
VIII  Aspirin (200 mg/kg p. o.)  0.50±0.01***  
The values were expressed as mean±SEM of 6 animals, Comparisons were made between: Group II with Group III, IV,V, VI, VII and VIII, Statistical 
significant test for comparison was done by one way ANNOVA, followed by Dunnet´s ‘t’test, ns-non significant, *p<0.05, **p<0.01, ***p<0.001. 
 
DISCUSSION 
Lipopolysaccharide, the principle components of all gram negative 
bacteria have been extensively studied as a major factor 
contributing to the pathogenesis of bacterial infections. LPS induces 
the production and release of inflammatory cytokines (IL-1, IL-6 and 
TNF-α) and COX enzymes of which several reactive oxygen species 
(ROS) are produced from cells (neutrophils, macrophages and other 
phagocytic cells) creating oxidative stress [19]. The inflammatory 
mediators relay signal to the CNS macrophages and microglia to 
produce the same cytokines, targeting neuronal substrates and 
eliciting sickness behaviour. Sickness behaviour is characterized by 
non-specific symptoms such as fever, prolong sleep, decrease in food 
and water intake, reduced mobility, depression and anxiety. 
Drugs that are useful in the treatment of LPS induced sickness 
behaviour includes Selective COX-1 inhibitors such as Resveratrol, 
SC-560, Selective COX-2 inhibitors such as Celecoxib,NS-398, Non 
Selective COX inhibitors such as Aspirin, Indomethacin, piroxicam 
etc., and Glucocorticoids such as dexamethasone. Aspirin is mostly 
used drug to treat neuroinflammation, as it inhibits predominantly 
COX-2 enzyme. Because of its ulcer inducing property, we moved to 
Resveratrol and Celecoxib to perform our study. 
In the present study, it was shown that the decrease in body weight 
and increase in rectal temperature was seen with the negative 
control group. Celecoxib treated group showed no changes in body 
weight before and after treatment but it showed the decrease in 
rectal temperature when compared to the negative control group 
and between before and after treatment.  
Locomotor activity was found to be decreased in negative control 
groups when compared with control group animals. Celecoxib (50 
mg/kg p. o) and Aspirin (100 and 200 mg/kg p. o) treated animals 
showed increase in locomotor activity when compared to Negative 
control group. Resveratrol did not show any difference in locomotor 
activity on comparing with negative control groups.  
The hole board test provides a simple method for measuring the 
response of an animal to an unfamiliar environment and is widely 
used to measure anxiety. It was shown that social exploratory 
behaviour such as head dipping and line crossing behaviour have 
been enhanced. In the present study Celecoxib at 10 and 50 mg/kg p. 
o. showed increase in both line crossings and head dipping whereas 
Resveratrol at 100 mg/kg showed increase in line crossings. 
Forced swimming test is a novel test to identify the depressant 
activity by measuring the floating time. In the present study, 
Celecoxib at dose of 50 mg/kg showed decrease in floating time 
when compared to negative control groups. Floating time have been 
increased in negative group animals when compared to control 
group animals.  
Antioxidants are being investigated for the ability to prevent 
cardiovascular, hepatic and pulmonary damage produced by LPS 
induced production of ROS, peroxides and cytokines. Because 
Jayashree et al. 
Int J Pharm Pharm Sci, Vol 7, Issue 6, 240-245 
245 
cytokines are behaviourally active, we hypothesize that antioxidants 
would inhibit LPS induced sickness behaviour. In our study, it 
revealed that Resveratrol shown to be effective against LPS induced 
behavioral alterations. Recent studies show treatment with 
antioxidants reduces ROS and TNF-α, IL-1β and IL-6 in LPS 
stimulated macrophages [20]. Resveratrol at doses 50 and 100 
mg/kg p. o. showed a significant increase in Superoxide dismutase, 
Catalase, Glutathione reductase levels but significantly decreases 
Lipid peroxidation level, NOx when compared to control animals.  
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